Daily IFN alpha 2b-ribavirin (R) combination for chronic hepatitis C (CHC) patients relapsing or non-responding to previous IFN administration: Preliminary report at 12 week.

Articles > Abstract · 1999

Authors: Abdullah Zeki KARASU, A Gurakar, A Jazzar, C Emmett, G McMillon, S Hulagu, H Wright

GASTROENTEROLOGY, Journal Indexed in SCI Expanded, International, 1999, vol 116